Clinical Trial Update: Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating peg-Interferon-α2b to decrease viral DNA in HIV-1 infection has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Peg Interferon α-2b (pegylated interferon alpha-2b)

Snippet

Sponsor: The Wistar Institute | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2023-07-06